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Abstract
Background: The course of self-reported symptoms during medium- versus long-term psychodynamic
psychotherapy has rarely been documented for outpatient settings. This observational study describes routine
practice of ambulatory treatment in Germany and explores self-reported symptoms of a broad patient sample
undergoing one (medium-term) versus two years (long-term) of psychodynamic psychotherapy.
Methods: Over four and a half years, longitudinal self-report symptom data were collected from 342 outpatients
as part of a standardized documentation system. Self-report data were compared between patients receiving either
medium-term or long-term psychodynamic psychotherapy.
Results: Routine care significantly decreased disease burden as reported by patients by small to medium effect
sizes (ES) for depression (ES = 0.58), anxiety (ES = 0.49), obsessive-compulsive disorder (ES = 0.54), somatoform
disorder (ES = 0.32), eating disorder (ES = 0.38). The majority of patients completed treatment after one year and
showed medium-size changes. For a subgroup of patients with depressive and/or obsessive-compulsive disorder
symptoms for whom two years of therapy were deemed necessary, additional benefits were reported during the
second year of treatment (ES = 0.61 and ES 0.47, respectively).
Conclusions: Our findings suggest that both medium- and long-term psychodynamic psychotherapy decrease
self-reported disease burden of patients with depression, anxiety, obsessive-compulsive, somatoform and/or eating
disorders. For a subgroup of patients, additional benefits were gained in the second year of treatment.
Keywords: Psychodynamic psychotherapy, Psychosomatic medicine, Longitudinal data, Symptom rating, Self-report data,
Outcomes assessment, Observational study
Background
The burden of mental illness is increasing worldwide [1],
with much debate that current estimations are even un-
derestimates of the true burden of mental and behavioral
disorders [2–4]. Besides psychopharmacological treat-
ment, psychotherapy is widely applied in Germany, and
physicians specialized in psychosomatic medicine apply
this type of treatment in approximately 65 % of their
patients [5]. In Germany, the provision of psychotherapy
according to approved guidelines is covered by the public
health insurance system. This includes cognitive behav-
ioral therapy (CBT) and psychodynamic psychotherapy
(including psychoanalyses). Both therapeutic approaches
have been proven to be effective and efficacious [6, 7].
However, these results are mostly derived from the so-
called “gold standard” in therapy research, the randomized
controlled trials (RCT) design. RCTs assure that effects
can be directly attributed to the specific treatment by
means of standardization and by randomly assigning pa-
tients to treatment or control groups [8]. Apart from eth-
ical issues, Westen et al. [9] expressed critique on the
application of RCTs in psychotherapy research, pointing
out the mismatch between the experimental setting and
psychotherapy practice in reality. One aspect is that in
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RCTs there are often manualized therapies for specific dis-
orders with an average of 20–30 sessions, whereas in clin-
ical reality outpatient psychotherapy is regularly provided
over the course of about 50–70 sessions depending on the
disorder [9]. Hence, evidence is needed for outcomes from
psychotherapy that takes place in a real-world setting
rather than in an artificial research environment.
Further, research to date has usually focused on
outcomes of short-term therapy, which generally found
effectiveness for a range of patients. However, research
also suggests that short-term psychotherapy may fail
specific subgroups of patients, for example, those affected
by complex mental disorders [10–13] for whom long-
term treatment may be necessary. As evidence from
research into long-term approaches is scarce, Leichsenring
and Rabung [14] undertook a meta-analysis on outcomes
of long-term psychodynamic psychotherapy from 23 stud-
ies. Their meta-analysis suggests superiority of long-term
over short-term treatment, with large effect sizes for afore-
mentioned subgroups of patients who do not sufficiently
benefit from short-term interventions [14]. While this
meta-analysis is an important contribution to the field, it
again also emphasizes the lack of research in this area as
only few studies could be included in the analysis. Further,
samples tended to be rather small, with a range of different
outcomes assessed via mostly different instruments. Most
importantly, included studies were frequently carried out in
inpatient settings and/or in artificial study environments
such as control group situations. While the latter is the
acknowledged gold standard, and it is a type of research
design that is crucial to ensure internal validity that allows
for causal inference as detailed above [15, 16], these settings
often lack clinical representativeness [14]. It therefore
remains that—even after such great effort to collate data on
outcomes from long-term therapy—evidence from real-
world psychodynamic psychotherapy in outpatient settings,
i.e. where most treatment takes place, remains scarce [17].
The aim of the present observational study is to give an
overview of outcomes from psychodynamic psychotherapy
and to describe the course of patient-reported symptom
severity over medium-term (one year) versus long-term
(two years) psychodynamic psychotherapy in an ambulatory
care setting. The paper addresses two research questions: 1)
Does the severity of patient-reported symptoms change
under medium- or long-term psychodynamic psychother-
apy? 2) Does a second year of therapy lead to additional
improvements in self-reported symptoms, i.e. is psycho-
dynamic psychotherapy beyond one year justified for cer-
tain subgroups of patients?
Methods
Study design and setting
Between June 2008 and December 2012 routine data
were collected from adult patients receiving either one
or two years of psychodynamic psychotherapy who were
treated in 13 outpatient clinics run by practice-based
Specialists for Psychosomatic Medicine and Psychother-
apy. Clinics were located in either Northern or Eastern
Germany, of which about half of the clinics were based
in Germany’s capital of Berlin.
We included consecutive patients who presented at
participating clinics as described above, with routine
data collected once per year. Patients had to be 18 years
or older, and be able to read and understand German.
Of above patient cohort, we excluded those who had
provided data within the last 15 months before closure
of the database as it could not be ruled out that these
patients were still in active psychotherapy. As these pa-
tients potentially would not yet have received the full
dose of treatment, it was important to exclude these to
receive valid estimates from the data that were collected.
Applying above criteria led to a final sample size of n =
342. Of these, 271 (79 %) patients received one year of
psychodynamic psychotherapy and 71 (21 %) patients
received two years of treatment.
Intervention
In Germany, psychotherapy (cognitive-behavioral ther-
apy and psychodynamic psychotherapy) is covered by
the public health insurance system. That is, costs for
short-term (up to 25 sessions), medium-term (25–50
sessions) as well as long-term therapies (maximum 80–
100 sessions for psychodynamic psychotherapy; up to
300 sessions for psychoanalyses) are reimbursed [18].
Psychodynamic psychotherapy embraces a comprehen-
sive curative approach that—in addition to purely focus-
ing on symptom-oriented relief—leads to a stronger
psychosocial capacity to cope with future challenges of
life. It focuses on revealing and verbalizing emotions.
This particularly applies to contradictory emotional
attitudes and efforts, and the potential for conflict to be
discovered which is clarified in everyday life as well as
within treatment. Habitual avoidance strategies are to be
experienced, understood, and changed. Recurring pat-
terns in interpersonal relationships as well as hidden
fantasies and motives are identified and explored
systematically. The life-historical process of formation of
reactions and attitudes is examined and integrated in the
personality of the patient. This applies to interpersonal
relationships outside as well as to the therapeutic
alliance itself, with the latter being the essential thera-
peutic agent [19, 20]. Psychodynamic psychotherapy
consists of individual and group sessions with both
carried out according to aforementioned principles.
While individual sessions may be scheduled in irregular
intervals, group sessions mostly occur regularly, that is,
usually once per week. Groups are generally mixed in
terms of sex, age, social status, and symptoms.
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In the current study, all patients received routine psy-
chodynamic psychotherapy as described above, including
both individual doctor-patient sessions and group ther-
apy with or without pharmacological treatment. As the
majority of patients received a mix of both approaches,
i.e. one-on-one sessions and group therapy, we applied
the following definition for patients to be considered as
mostly receiving “group therapy”: >60 % of the sessions
received were group therapy sessions with >10 group
therapy sessions attended. Patients not fulfilling these
criteria were considered as patients receiving “one-on-
one”. Although treatment intensity and quantity differed
between patients, with the schedule ranging from low-
frequency sessions once a week or once every two weeks
up to high frequency arrangements with two to three
sessions per week, it needs to be noted that treatment
provided by Specialists for Psychosomatic Medicine and
Psychotherapy is regulated in Germany. That is, the thera-
pists are obliged to follow treatment methods that have
been scientifically approved and are included in the cata-
logues of services of the German statutory insurance funds.
The continuing medical education includes supervised
short-, medium- and long-term outpatient psychotherapy,
regular meetings with colleagues for therapeutic self-
awareness sessions, and inpatient clinical training. Hence,
all therapists who provide psychodynamic psychotherapy in
the psychosomatic medicine setting are qualified in short-,
medium- and long-term psychodynamic treatment.
Data documentation system
At collaborating institutions, patient data were collected
routinely using the Documentation System in Psycho-
somatic medicine (DSP). Patients filled in questionnaires
on 1) socio-demographic data including use of healthcare
services and 2) the ICD-10-Symptom-Rating (ISR) scale
[21], whereas therapists filled in questionnaires on 3) diag-
noses based on the German ICD-classification system ICD-
10-GM [22] and 4) use of other health care services [17].
In view of socio-demographic data both sex and age
were available from patients’ health records. Education,
employment status, nationality, and relationship status
were assessed via patient self-report. For this paper,
education was grouped following the categorization as
recommended by the German Federal Ministry of
Health and used in many federally funded projects [23].
The ISR, developed in Germany, assesses patient-
reported symptoms [21] based on chapter F, ICD-10-
GM [22]. The ISR aims at assessing presence as well as
severity of self-reported symptoms. It consists of 29
items, of which 17 form the five subscales depressive (4
items), anxiety (4 items), obsessive-compulsive (3 items),
somatoform (3 items), and eating disorder (3 items)
symptoms. The remaining 12 items can be used as a
screening instrument for single syndromes. In this paper
we use the former five subscales only as these measure
distinct aspects of mental health [24]. The ISR items are
scored on a 5-point Likert scale ranging from 0 (‘Does
not apply’) to 4 (‘Extremely applies’). Subscale scores are
calculated by forming the average of respective re-
sponses per individual subscale; hence, scores in a given
subscale range from 0 (no symptoms) to 4 (maximum
amount of self-reported symptoms). The psychometric
properties of the ISR have been shown to be very strong,
with evidence that it is largely robust against potential
confounding effects such as response shift when measur-
ing change over time [25]. Further details on the ISR can
be found elsewhere [21].
Statistical analyses
All analyses are based on the most prevalent diagnoses
in ambulatory psychosomatic care. The following diagnoses
based on ICD-10-GM [22] were selected: depressive
disorder (F32.- to F39), anxiety disorder (F40.- to F41.-),
obsessive-compulsive disorder (F42.-), somatoform disorder
(F45.-), eating disorder and obesity (F50.-; E66.-). Obesity
was included because of its increasing relevance and lack of
a corresponding diagnosis in ICD-10-GM chapter F.
Demographic data assessed at baseline (T0) are pre-
sented descriptively, comparing patients receiving one
year versus those receiving two years of psychodynamic
psychotherapy, using chi-square and t-test statistics for
independent samples. Further, the most frequently re-
ported diagnoses based on the ICD-10-GM as docu-
mented by respective clinician and the number of
comorbidities are compared between groups, with special
emphasis on those diagnoses of chapter F with a corre-
sponding subscale in the ISR. Symptom severity, as mea-
sured by the ISR at baseline (T0), was compared between
groups using robust ANOVA Brown-Forsythe [26].
For longitudinal analyses, both raw mean ISR scores
and effect sizes (ES) were compared a) longitudinally
within each group and b) between groups, i.e. patients
who received one year versus those who received two
years of psychodynamic psychotherapy. For the compari-
son of raw mean ISR scores, one-sample t-tests were
calculated. For the comparison of effects sizes, ES were
calculated by taking the ISR difference score divided by
the standard deviation (SD) at baseline [27]. Interpret-
ation of ES followed Cohen’s suggestion for interpreting
effect size d, with ES ~ 0.2 considered a small, ES ~ 0.5 a
medium, ES ~ 0.8 a large effect [27]. All analyses were
carried out using IBM SPSS Statistics 22.0®.
Ethical considerations and data protection
As self-reported symptom data were acquired as part of
routine patient assessment, i.e. the aforementioned DSP.
Each patient was informed about the study and had to
provide written informed consent at baseline which
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included the right to decline participation in this study.
Less than 1 % declined participation.
All data were pseudonymized with unique identifica-
tion numbers assigned to each individual patient to en-
sure linkage of longitudinal data. Those responsible for
the data cleaning, analyses, interpretation of results, and
writing up of the manuscript (SN, LE, FF, MR) did not
have access to patient names at any time but were
blinded to any possible identification of individual
patients.
Results
Baseline characteristics of patients with one year of psy-
chodynamic psychotherapy (n = 271) compared to those
with two years of therapy (n = 71) are presented in
Table 1. Overall, more women (65 %) compared with
men (35 %) received psychodynamic psychotherapy.
Mean age of patients was 45.5 (SD = 12.0) years; about
40 % stated to be single. As shown in Table 2, less than
10 % of patients were diagnosed with a single disease
based on ICD-10-GM but the majority of patients had
one or more comorbidities, with an average of 4.27 (SD
= 2.46) documented diagnoses. When comparing pa-
tients receiving medium- with those receiving long-term
therapy, the latter group showed a higher mean of diag-
noses, with 4.12 (SD = 2.40) diagnoses for patients in
medium-term and 4.85 (SD = 2.63) diagnoses for pa-
tients in long-term therapy (p = .027). In view of chapter
F of ICD-10-GM, the most common clinical diagnosis
was depression (61 %) followed by anxiety (37 %) and
somatoform disorder (28 %). Patients with somatoform
disorders were more likely to receive long-term psycho-
therapy (χ2 = 4.997, p = .025), while there were no statis-
tically significant differences between patients receiving
one year versus those receiving two years of therapy for
other diagnostic groups within chapter F. There were
small, albeit not statistically significant, trends towards
an increase of the proportion of women and those with
a clinical diagnosis of depression, obsessive-compulsive
disorder, and somatoform disorder in the group of
patients receiving long-term psychodynamic psychother-
apy. As for diagnoses based on other chapters of the
ICD-10-GM, the most frequently documented diagnoses
were back pain (M54.-) recorded 61 times, sleep disor-
ders (G47.-) recorded 43 times, and migraines and head-
aches (G43.-, G44.-) recorded 39 times (Table 2).
Regarding doctor-patient encounters per year, an average
of 34.1 (SD = 21.2) scheduled meetings were recorded for
the total sample (n = 342). While there was a trend towards
those receiving two years of psychodynamic psychotherapy
having more doctor-patient encounters, particularly in their
first year of therapy (M= 38.2, SD = 23.8), compared to
those with one year of treatment (M= 33.0, SD = 20.3),
differences were not statistically significant. As shown in
Table 3, there was also no statistically significant difference
with regard to group versus one-on-one treatment between
patients receiving medium- versus long-term psycho-
dynamic psychotherapy (medium-term: n = 207 (76 %)
one-on-one; long-term: n = 49 (70 %) one-on-one).
In view of self-reported symptoms at baseline (T0) as
measured by the ICD-10-Symptom-Rating scale, no
significant differences were observed between patients
receiving medium- versus those receiving long-term
psychodynamic psychotherapy. Patients’ mean ISR scores
Table 1 Baseline characteristics of patients treated by German
practice-based Specialists for Psychosomatic Medicine; total
sample (n = 342), comparison of patients with one year (n = 271)







n = 342 n = 271 n = 71
n % n % n %
Gender
Male 125 36.5 104 38.4 21 29.6
Female 217 63.5 167 61.6 50 70.4
Age in years
Mean (SD) 45.5 (12.0) 45.9 (12.1) 44.0 (11.4)
Range 22–81 22–81 26–75
Age groups
up to 30 years 36 10.5 28 10.3 8 11.3
30–39 years 77 22.5 57 21.0 20 28.2
40–49 years 92 26.9 74 27.3 18 25.4
50–59 years 99 28.9 80 29.5 19 26.8
60+ years 38 11.1 32 11.8 6 8.5
Educationa
Year 9 or less 37 10.8 30 11.2 7 9.9
Year 9 w/ prof. training 48 14.0 37 13.8 11 15.5
Year 10 w/ prof. training 98 28.7 80 29.7 18 25.4
Year 13, w/ or w/out
prof. training
84 24.6 64 23.8 20 28.2
Year 13, w/ university 73 21.3 58 21.6 15 21.1
Employment status
Full-time 142 41.5 112 41.3 30 42.3
Part-time 61 17.8 52 19.2 9 12.7
Unemployed 48 14.0 35 12.9 13 18.3
Other 91 26.6 72 26.6 19 26.8
Relationship status
No partner 134 39.2 105 38.7 29 40.8
Married 115 33.6 92 33.9 23 32.4
Partner, not married 93 27.2 74 27.3 19 26.8
aEducation following categorization as applied in the German national KiGGS
Survey (Lange et al., 2007)
*Significant group differences at p < .05 level (chi-square tests; for age: t-test
statistic for independent samples)
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were comparable across self-reported depressive, anxiety,
obsessive-compulsive, somatoform, and eating disorder
symptoms (Table 4). When selecting only those patients
who had a positive clinical diagnosis corresponding to the
symptoms as measured by the ISR, self-reported symp-
toms at baseline again did not differ between the two
groups receiving different lengths of treatment (data not
shown). For longitudinal assessment, symptom severity as
shown by raw mean ISR scores decreased significantly be-
tween T0 and follow-up (T1) in both groups across all five
ISR domains, with the exception of eating disorder in the
group of patients with two years of treatment. This group
reported ISR scores at T1 that were worse compared to
those they had reported at T0. For the group of patients
with two years of treatment, a third measurement time
point of self-reported symptoms was available. As shown
in Table 4 at the bottom of the rightmost column, com-
pared to their ISR at T0 as well as their first follow-up
scores (T1), this group of patients showed significant im-
provements across all five ISR domains at their last
measurement time point (T2), reflected in a decrease in
self-reported ISR scores.
Longitudinal data were further investigated by calcu-
lating effect sizes. These analyses again suggest that
symptom burden decreased significantly as a result of
psychodynamic psychotherapy, with a comparable
course of self-reported symptoms for both groups, i.e.
the group of patients with medium-term and the group
of patients with long-term psychodynamic psychother-
apy reported a decrease in self-reported symptoms over
time. That is, at the end of respective treatment (T1 for
medium-term, T2 for long-term therapy) the total sam-
ple of patients with a positive clinical diagnosis of the
disorders investigated in this study reported improve-
ments ranging from ES = 0.32 (95 % CI: 0.18,0.47) for
somatoform disorder symptoms to ES = 0.58 (95 % CI:
0.45,0.70) for depressive symptoms (Table 5, first col-
umn). In contrast, subgroup analyses showed that
groups’ effect sizes differed when basing ES on the com-
parison of T0 with T1 scores, i.e. a point in time when
Table 2 Overview of reported diagnoses at baseline as documented by clinician and overview of most frequently recorded
diagnoses by chapter ICD-10-GM; total sample (n = 342), comparison of patients with one year (n = 271) versus those with two years







n = 342 n = 271 n = 71
n % n % n %
Diagnoses (ICD-10-GM)
Number of diagnoses (mean, SD)* 4.27 (2.46) 4.12 (2.40) 4.85 (2.63)
1 diagnosis 31 9.1 26 9.6 5 7.0
2–5 diagnoses 222 64.9 182 67.2 40 56.3
6–10 diagnoses 89 26.0 63 23.2 26 36.6
Chapter F (Mental and behavioral disorders)a
Depression (F32.- to F39) 208 60.8 159 58.7 49 69.0
Anxiety (F40.- to F41.-) 128 37.4 100 36.9 28 39.4
Obsessive-compulsive disorder (F42.-) 43 12.6 30 11.1 13 18.3
Somatoform disorder (F45.-)* 94 27.5 67 24.7 27 38.0
Eating disorder (F50.-; E66.-) 68 19.9 51 18.8 17 23.9
Presence of ≥1 other diagnoses chapter F 206 60.2 163 60.1 43 60.6
Chapter E (Endocrine, nutritional, metabolic)
Presence of ≥1 diagnoses chapter E 58 17.0 45 16.6 13 18.3
Chapter G (Diseases of nervous system)
Presence of ≥1 diagnoses chapter G 83 24.3 67 24.7 16 22.5
Chapter M (Musculoskeletal system)
Presence of ≥1 diagnoses chapter M 78 22.8 61 22.5 17 23.9
Other (predominantly chapters I, K and R)
Presence of ≥1 further diagnoses* 182 53.2 136 50.2 46 64.8
aAs patients were frequently diagnosed with more than one clinical diagnosis (ICD-10-GM), the sum of diagnoses is larger than the total sample size because
of co-morbidities
*Significant group differences at p < .05 level (chi-square tests; for mean number of diagnoses: t-test statistic for independent samples)
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patients with medium-term therapy had completed
treatment, while those who received long-term therapy
were still in active treatment (Table 5, second versus
third column). Significant group differences were found
for self-reported somatoform and eating disorder symp-
toms. Marked, albeit not statistically significant, differ-
ences were also seen for depressive and obsessive-
compulsive disorder symptoms. Finally, when basing
each group’s ES on respective maximum follow-up ISR
score, i.e. a point in time when all patients had com-
pleted treatment, however, differences between the two
groups were not statistically significant anymore (Table 5,
second versus fourth column).
For depressive, anxiety, and obsessive-compulsive dis-
order symptoms, ES across groups were of medium size.
In contrast, ES for somatoform disorder symptoms were
small, particularly for the group receiving long-term
therapy. For eating disorder symptoms, the group receiv-
ing medium-term psychodynamic psychotherapy almost
reached medium-size ES, while effects were substan-
tially, although not significantly, smaller for the group in
long-term therapy (Fig. 1).
Discussion
This observational study was aimed at investigating
the course of self-reported symptoms as reported by
patients receiving medium-term (1 year) compared to
those receiving long-term (2 years) psychodynamic
psychotherapy, with a treatment regime following
established methods typical for German psycho-
somatic outpatient care [28].
Baseline data suggest that patients who receive
medium- or long-term psychodynamic psychotherapy
not only suffer from a wide range of mental and behav-
ioral disorders but also have a high prevalence of add-
itional disorders, with the vast majority of patients
having both mental and somatic comorbidities. Patients
were characterized by medium age (mean age 45 years),
with about two thirds being women. It is noteworthy
that hardly any statistically significant differences were
found between patients receiving medium-term com-
pared to patients receiving long-term psychodynamic
psychotherapy. That is, overall neither baseline charac-
teristics nor patients’ self-reported symptoms as
measured by the ISR were associated with treatment
length. The only trends were that the group of patients
receiving long-term therapy regularly showed a higher
prevalence of a range of diagnoses, with statistically
significant differences for mean number of diagnoses
with those in long-term therapy showing a higher mean
number of diagnoses; however, group differences by
diagnostic groups were mostly not statistically signifi-
cant. Further, the female-to-male ratio was also some-
what higher in the group of patients in long-term
therapy. While it is conceivable that compliance to psy-
chotherapy among women is higher compared to men,
Table 3 Distribution of types of treatment (one-on-one versus group therapy) for diagnostic subgroups; total sample (n = 342),
and patients receiving medium-term (n = 271) versus patients receiving long-term psychodynamic psychotherapy (n = 71)
Total sampleb Treatment 1 year Treatment 2 years
n = 342 n = 271 n = 71
n % n % n %
One-on-One
Total Sample 256 74.9 207 76.4 49 69.0
Depressive Disordera (F32.- to F39) 148 71.2 115 72.3 33 67.3
Anxiety Disorder (F40.- to F41.-) 97 75.8 77 77.0 20 71.4
Obsessive Compulsive Disorder (F42.-) 14 32.6 11 36.7 3 23.1
Somatoform Disorder (F45.-) 62 66.0 45 67.2 17 63.0
Eating Disorder (F50.-; E66.-) 57 83.8 42 82.4 15 88.2
Group Therapy
Total Sample 86 25.1 64 23.6 22 31.0
Depressive Disorder (F32.- to F39) 60 28.8 44 27.7 16 32.7
Anxiety Disorder (F40.- to F41.-) 31 24.2 23 23.0 8 28.6
Obsessive Compulsive Disorder (F42.-) 29 67.4 19 63.3 10 76.9
Somatoform Disorder (F45.-) 32 34.0 22 32.8 10 37.0
Eating Disorder (F50.-; E66.-) 11 16.2 9 17.6 2 11.8
aAs patients were frequently diagnosed with more than one clinical diagnosis (ICD-10-GM), the sum of diagnoses is larger than the total sample size because
of co-morbidities
bThe distribution between one-on-one and group therapy did not differ significantly between patients receiving one versus those receiving two years
of treatment
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this possible explanation cannot be substantiated follow-
ing two meta-analyses on discontinuation of psychother-
apy where no such connection was found [29, 30].
Regarding longitudinal assessment, our data suggest that
self-reported symptom burden decreased significantly over
time. When expressed in terms of effect sizes, small to
medium ES across all main health domains were found,
with largest ES observed for depressive, anxiety, and
obsessive-compulsive disorder symptoms. Further, we
found that the subgroup of patients that required two years
of therapy (n = 71) showed rather small ES at T1, i.e. at a
point in time when their treatment was still ongoing. That
is, ES were consistently smaller compared to the group of
patients who had completed treatment at that point (n =
271). At T2, i.e. a point in time when the former group was
considered as having completed their therapy as well, differ-
ences in ES between the two groups were not statistically
significant anymore. Even though this is not a classic dose-
effect-model as investigated by others [10], our findings
suggest that long-term psychodynamic psychotherapy
seems justified for this particular subgroup as many of these
patients had not reached saturation at T1. However, when
comparing the five diagnostic groups explored in this study,
this is only true for patients with depressive or obsessive-
compulsive disorders. Patients with anxiety disorders did
not show further improvements in the additional year of
treatment, and the small group of patients with somato-
form or eating disorders—who did not show any improve-
ment in self-reported symptoms within the first year of
treatment—did not in their second year either.
The comparison of our results to other studies in this
area is somewhat difficult. To our knowledge, there are
only few studies in the field of psychodynamic psycho-
therapy that explore treatment outcomes from medium-
or long-term therapy in an outpatient setting such as the
one presented herein. An overview of long-term psycho-
dynamic psychotherapy is provided in aforementioned
meta-analysis [14], which includes studies reporting
treatment outcomes that were assessed in the context of
an observational study design similar to ours. However,
studies that were included have limited comparability to
our study sample. Those that seem largely comparable
showed similar effect sizes [31–33].
Our study provides an overview of the course of self-
reported symptoms collected as part of a widely imp-
lemented routine health outcomes assessment for
Table 4 ICD-Symptom-Rating (ISR) scores at baseline (T0), 1-year follow-up (T1), 2-year follow-up (T2); total sample and comparison
of patients with one year of treatment (n = 271) versus those with two years of treatment (n = 71)
ISR scalea Total sample Treatment 1 year Treatment 2 years
n = 342 n = 271 n = 71
mean (SD) mean (SD) mean (SD)
Baseline (T0)
Depressive symptoms 2.04 (0.97) 2.07 (0.98) 1.96 (0.93)
Anxiety symptoms 1.86 (1.08) 1.84 (1.08) 1.91 (1.06)
Obsessive-compulsive disorder symptoms 1.52 (1.09) 1.56 (1.09) 1.35 (1.07)
Somatoform symptoms 0.85 (1.03) 0.84 (1.04) 0.89 (0.99)
Eating disorder symptoms 0.84 (1.07) 0.84 (1.09) 0.85 (1.01)
1-year follow-up (T1)
Depressive symptoms 1.56 (0.95)* 1.55 (0.94)* 1.56 (0.96)*
Anxiety symptoms 1.54 (1.03)* 1.51 (1.03)* 1.65 (1.00)*
Obsessive-compulsive disorder symptoms 1.22 (0.99)* 1.20 (0.99)* 1.30 (0.99)*
Somatoform symptoms 0.67 (0.82)* 0.63 (0.79)* 0.79 (0.93)*
Eating disorder symptoms 0.81 (0.98)* 0.78 (0.98)* 0.91 (0.98)*
2-year follow-up (T2)
Depressive symptoms 1.31 (0.87)*
Anxiety symptoms 1.47 (0.93)*
Obsessive-compulsive disorder symptoms 1.05 (1.02)*
Somatoform symptoms 0.55 (0.74)*
Eating disorder symptoms 0.80 (0.76)*
Note, there were no significant differences between the group with one year compared with the group with two years of treatment regardless of which follow-up
scores were compared
aISR items are scored from 0 to 4; subscale scores are calculated by forming the average of respective responses; hence, mean scores in a given subscale range
from 0 (no self-reported symptoms) to 4 (maximum amount of self-reported symptoms)
*Significant differences at p < .05 level (robust ANOVA, Brown-Forsythe) between respective Baseline, 1-year, and 2-year follow-up scores
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Table 5 ISR difference scores (based on effect sizes [ES]a) of patients with a positive clinical diagnosis (depression, anxiety, obsessive-compulsive, somatoform and/or eating dis-
orders) matched to according self-report ISR scores; total sample (n = 342)
and comparison of patients with one year of treatment (n = 271) versus those with two years of treatment (n = 71)
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aEffect sizes (ES) interpreted as small (ES ~ 0.2), medium (ES ~ 0.5) or large (ES ~ 0.8) effects (Cohen, [27])
bES based on Tmax (maximum), i.e. ES are based on the latest follow-up ISR data available, i.e. T1 (n = 271) and T2 (n = 71), respectively
cES based on (T1-T0), i.e. this group’s first follow-up score
dES based on (T2-T0), i.e. this group’s final follow-up score
*Significant differences at p < .05 level (robust ANOVA, Brown-Forsythe for the comparison of patients with one year of treatment [n = 271] versus those with two years of treatment [n = 71], with the latter group











psychosomatic care in Germany. The main finding is that
a clinically meaningful reduction of self-reported disease
burden was demonstrated over time of treatment for both
medium- and long-term psychodynamic psychotherapy.
This finding highlights the strengths of psychodynamic
psychotherapy. This type of therapy does not primarily
focus on symptom relief but it aims at helping the patient
to get a more comprehensive view of her-/himself and to
reveal unconscious motives in her/his behavioral patterns
and interpersonal relationships. It is assumed that achiev-
ing these aims leads to a decrease in symptoms. This de-
crease in self-reported symptoms was also observed in our
study. However, despite the small to medium alleviation of
patient-reported symptom burden as found in our obser-
vational study, it remains unclear whether the specific ef-
fect is attributable to the intervention alone. To address
the comparative effectiveness of ambulatory psycho-
dynamic psychotherapy in a real-world setting, a cohort
study would be necessary to attribute benefits to the treat-
ment as provided, including appropriate control groups,
to ensure internal validity of our results [15, 16]. More-
over, patient-reported outcomes assessments should also
include further variables, such as the change of functional
impairments or impact in daily life under psychotherapy.
Nevertheless, we believe that in our study we were able to
provide a good overview of the course of self-reported
symptoms obtained from real-world medium- versus
long-term psychodynamic psychotherapy under routine
care conditions.
Conclusion
Our paper is based on data collected under routine care
conditions. That is, data were obtained from a clinical
population that is likely to be representative of current psy-
chosomatic care in Germany, which has not yet received
sufficient attention in the literature. In summary, patients
from a wide range of backgrounds undergo psychodynamic
psychotherapy in the German ambulatory psychosomatic
care setting, with those receiving medium-term or long-
term psychodynamic psychotherapy reporting a small to
medium size decrease in self-reported symptom burden
across a range of health domains. Our analyses further
show that patients who are in treatment for two years re-
port small benefits within the first year of therapy but gain
additional benefits during the second year of therapy. This
supports the notion that this subgroup may need more
time to respond to psychodynamic psychotherapy. Overall,
our study shows that psychodynamic psychotherapy im-
proves symptom severity in a wide range of mental
disorders.
Fig. 1 Effect sizes (ES) of patients receiving medium-term psychosomatic treatment (1 year) compared to those with long-term treatment
(2 years) across five ISR domains
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